Gil Labrucherie
Board Member
Rezolute, Inc. (RZLT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gil Labrucherie
Gil Labrucherie is recorded as Board Member at Rezolute, Inc. (RZLT). Gil Labrucherie was last confirmed as CFO at Nektar Therapeutics (NKTR) in a filing dated April 28, 2023. Earlier roles on record: COO and CFO at Nektar Therapeutics (NKTR) until July 1, 2022. Gil Labrucherie has spoken on 7 earnings calls across 1 company, most recently for Nektar Therapeutics on January 11, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2022-07-01
-
Start not stated–2022-07-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rezolute, Inc.
Other people whose current roles at this company are on record from its filings.
- Nevan Charles Elam CEO
- Nevan Elam CEO
- Young-Jin Kim Chairman, Board Member
- Daron Evans CFO
- Erik Harris Board Member
- Nerissa C. Kreher Board Member
- Nerissa Kreher Board Member
- Philippe Fauchet Board Member
- Vlad Hogenhuis Board Member
- Wladimir Hogenhuis Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.